Erythropoietin mediates hepcidin expression in hepatocytes through EPOR signaling and regulation of C/EBPα

Blood

Volumn 111, Issue 12, 2008, Pages 5727-5733

  Pinto, Jorge P ^a   Ribeiro, Sara ^a   Pontes, Helena ^b   Thowfeequ, Shifaan ^c   Tosh, David ^c   Carvalho, Félix ^b   Porto, Graça ^a,b,d  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c University of Bath   (United Kingdom)

^d HOSPITAL DE SANTO ANTÓNIO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN ALPHA; ERYTHROPOIETIN RECEPTOR; HEPCIDIN; RECOMBINANT ERYTHROPOIETIN; ANTIBODY; ANTIMICROBIAL CATIONIC PEPTIDE; ERYTHROPOIETIN; HAMP2 PROTEIN, MOUSE; MESSENGER RNA;

ANEMIA; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ERYTHROPOIESIS; GENE EXPRESSION; HUMAN; HUMAN CELL; HYPOXIA; IRON KINETICS; LIVER CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; ANIMAL; C57BL MOUSE; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; GENETICS; IMMUNOLOGY; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; PHYSIOLOGY; PROMOTER REGION; TUMOR CELL LINE;

ANIMALS; ANTIBODIES; ANTIMICROBIAL CATIONIC PEPTIDES; CARCINOMA, HEPATOCELLULAR; CCAAT-ENHANCER-BINDING PROTEIN-ALPHA; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROPOIESIS; ERYTHROPOIETIN; GENE EXPRESSION; HEPATOCYTES; HUMANS; LIVER NEOPLASMS; MICE; MICE, INBRED C57BL; PROMOTER REGIONS (GENETICS); RECEPTORS, ERYTHROPOIETIN; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 47049116150     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2007-08-106195     Document Type: Article

References (37)

1. Nerneth E, Ganz T. Regulation of iron metabolism by hepcidin. Annu Rev Nutr. 2006;26:323-342.
2. Nerneth E, Tuttle MS, Powelson J, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science. 2004;306:2090-2093.
3. Finch G. Regulators of iron balance in humans. Blood. 1994;84:1697-1702.
4. Eckardt K-U, Kurtz A. Regulation of erythropoietin production. Eur J Clin Invest. 2005;35(suppl 3): 13-19.
5. Tan CC, Eckardt KU. Firth JD, Ratcliffe PJ. Feedback modulation of renal and hepatic erythropoietin mRNA in response to graded anemia and hypoxia. Am J Physiol. 1992;263:F474-F481.
6. Nicolas G, Viatte L Bennoun M, Beaumont C, Kahn A. Vaulont S. Hepcidin, a new iron regulatory peptide. Blood Cells Mol Dis. 2002;29:327-335.
7. Fein E, Merle U, Ehehalt R, Herrmann T, Kulaksiz H. Regulation of hepcidin in HepG2 and RINm5F cells. Peptides. 2007;28:951-957.
8. Gehrke SG, Kulaksiz H, Herrmann T, et al. Expression of hepcidin in hereditary hemochromatosis: evidence for a regulation in response to the serum transferrin saturation and to nontransferrin-bound iron. Blood. 2003;102:371-376.
9. YasudaY, FujitaY, MatsuoT, etal. Erythropoietin regulates tumour growth of human malignancies. Carcinogenesis. 2003;24:1021 -1029.
10. Lin L, Valore EV, Nerneth E, Goodnough JB; Gabayan V. GanzT. Iron-transferrin regulates hepcidin synthesis in primary hepatocyte culture through hemojuvelin and BMP2/4. Blood. 2007; 110:2182-2189.
11. Moldéus P. Högberg J. Orrenius S. Isolation and use of liver cells. Methods Enzymol. 1978;52:60-71.
12. Carvalho M, Carvalho F. Bastos ML. Is hyperthermia the triggering factor for hepatotoxicity induced by 3,4-methylenedioxymethamphetamine (ecstasy)? an in vitro study using freshly isolated mouse hepatocytes. Arch Toxicol. 2001 ;74:789-793.
13. Grimm C, Wenzel A, Stanescu D, et al. Constitutive overexpression of human erythropoietin protects the mouse retina against induced but not inherited retinal degeneration. J Neurosci. 2004; 24:5651-5658.
14. Cynshi O, ShimonakaY, Higuchi M, etal. Effects of recombinant human erythropoietin on hemolytic anaemia in mice. Br J Haematol. 1990;76: 414-419.
15. Abramoff MD. Magalhães PJ, Ram SJ. Image processing with Image J. Biophoton Int. 2004;11: 36-42.
16. Nerneth E, Rivera S, Gabayan V, et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest. 2004;113:1271-1276.
17. De La Brousse FC; Shan B, Chen J-L. Identification of the promoter of the mouse obese gene. Proc Natl Acad Sci U SA. 1996;93:4096-4101.
18. Jover R, Bort R, Gómez-Lechón MJ, Castell JV. Re-expression of C/EBP alpha induces CYP2B6, CYP2C9 and CYP2D6 genes in HepG2 cells. FEBS Lett. 1998;431:227-230.
19. TomizawaM, SaishoH. Insulin-like growth factor (IGF)-II regulates CCAAT/enhancer binding protein alpha expression via phosphatidyl-inositol 3 kinase in human hepatoblastoma cell lines. J Cell Biochem. 2007;102:161-170.
20. Chew CH; Chew GS, Najimudin N, Tengku-Muhammad TS. lnterleukin-6 inhibits human peroxisome proliferator activated receptor alpha gene expression via CCAAT/enhancer-binding proteins in hepatocytes. Int J Biochem Cell Biol. 2007;39:1975-1986.
21. Yoon K, Smart RC. C/EBPalpha is a DNA damage-inducible p53-regulated mediator of the G1 checkpoint in keratinocytes. Mol Cell Biol. 2004; 24:10650-10660.
22. Choi SO, Cho YS, Kim HL, Park JW. ROS mediate the hypoxic repression of the hepcidin gene by inhibiting C/EBPalpha and STAT-3. Biochem Biophys Res Commun. 2007;356:312-317.
23. Tomizawa M, Saisho H. Insulin-like growth factor (IGF)-II regulates CCAAT/enhancer binding protein alpha expression via phosphatidyl-inositol 3 kinase in human hepatoblastoma cell lines. J Cell Biochem. 2007;102:161-170.
24. Shim M, Smart RC. Lithium stabilizes the CCAAT/ enhancer-binding protein alpha (G/EBPalpha) through a glycogen synthase kinase 3 (GSK3)-independent pathway involving direct inhibition of proteasomal activity. J Biol Ghem. 2003;278: 19674-19681.
25. Weizer-Stern O, Adamsky K. Amariglio N. et al. Downregulation of hepcidin and haemojuvelin expression in the hepatocyte cell-line HepG2 induced by thalassaemic sera. Br J Haematol. 2006;135:129-138.
26. Pak M, Lopez MA, Gabayan V, Ganz T, Rivera S. Suppression of hepcidin during anemia requires erythropoietic activity. Blood. 2006;108:3730-3735.
27. Courselaud B, Pigeon C, Inoue Y, et al. C/EBPalpha regulates hepatic transcription of hepcidin. an antimicrobial peptide and regulator of iron metabolism: cross-talk between C/EBP pathway and iron metabolism. J Biol Chem. 2002;277:41163-41170.
28. Harrison-Findik DD, Schafer D, Klein E, et al. Alcohol metabolism-mediated oxidative stress down-regulates hepcidin transcription and leads to increased duodenal iron transporter expression. J Biol Chem. 2006;281:22974-22982.
29. Nishina S, Hino K, Korenaga M, et al. Hepatitis C virus-induced reactive oxygen species raise hepatic iron level in mice by reducing hepcidin transcription. Gastroenterology. 2008;134:226-238.
30. Ron D. Habener JF. CHOP, a novel developmen-tally regulated nuclear protein that dimerizes with transcription factors C/EBP and LAP and functions as a dominant-negative inhibitor of gene transcription. Genes Dev. 1992;6:439-453.
31. Coutts M, Cui K, Davis KL Keutzer JC, Sytkowski AJ. Regulated expression and functional role of
32. the transcription factor CHOP (GADD153) in ery- throid growth and differentiation. Blood. 1999;93: 3369-3378.
33. Tan CC; Eckardt KU, Ratcliffe PJ. Organ distribution of erythropoietin messenger RNAin normal and uremic rats. Kidney Int. 1991 ;40:69-76.
34. Farrell F, Lee A. The erythropoietin receptor and its expression in tumor cells and other tissues. Oncologist. 2004;9(suppl 5): 18-30.
35. Schmidt EK. Fichelson S, Feller SM. PI3 kinase is important for Ras, MEK and Erk activation of Epo-stimulated human erythroid progenitors. BMC Biol (http://www.biomedcentral.com/ bmcbiol/). 2004;2:7.
36. Jie KE, Verhaar MC, Cramer MJ, et al. Erythropoietin and the cardiorenal syndrome: cellular mechanisms on the cardiorenal connectors. Am J Physiol Renal Physiol. 2006;291 :F932-F944.
37. Tanno T, Bhanu NV, Oneal PA, et al. High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin. Nat Med. 2007;13:1096-1101.